JP2015526497A5 - - Google Patents

Download PDF

Info

Publication number
JP2015526497A5
JP2015526497A5 JP2015529082A JP2015529082A JP2015526497A5 JP 2015526497 A5 JP2015526497 A5 JP 2015526497A5 JP 2015529082 A JP2015529082 A JP 2015529082A JP 2015529082 A JP2015529082 A JP 2015529082A JP 2015526497 A5 JP2015526497 A5 JP 2015526497A5
Authority
JP
Japan
Prior art keywords
medicament according
selective agonist
brl37344
pharmaceutically acceptable
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015529082A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015526497A (ja
JP6539206B2 (ja
Filing date
Publication date
Priority claimed from ES201231343A external-priority patent/ES2394349B1/es
Application filed filed Critical
Publication of JP2015526497A publication Critical patent/JP2015526497A/ja
Publication of JP2015526497A5 publication Critical patent/JP2015526497A5/ja
Application granted granted Critical
Publication of JP6539206B2 publication Critical patent/JP6539206B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015529082A 2012-08-29 2013-08-28 肺高血圧症の治療のためのベータ−3アドレナリン受容体アゴニストの使用 Expired - Fee Related JP6539206B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201231343 2012-08-29
ES201231343A ES2394349B1 (es) 2012-08-29 2012-08-29 Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar
PCT/ES2013/070611 WO2014033343A1 (es) 2012-08-29 2013-08-28 Agonistas de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar

Publications (3)

Publication Number Publication Date
JP2015526497A JP2015526497A (ja) 2015-09-10
JP2015526497A5 true JP2015526497A5 (cg-RX-API-DMAC7.html) 2016-10-13
JP6539206B2 JP6539206B2 (ja) 2019-07-03

Family

ID=47520452

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015529082A Expired - Fee Related JP6539206B2 (ja) 2012-08-29 2013-08-28 肺高血圧症の治療のためのベータ−3アドレナリン受容体アゴニストの使用

Country Status (6)

Country Link
US (1) US10532038B2 (cg-RX-API-DMAC7.html)
EP (1) EP2891490B1 (cg-RX-API-DMAC7.html)
JP (1) JP6539206B2 (cg-RX-API-DMAC7.html)
DK (1) DK2891490T3 (cg-RX-API-DMAC7.html)
ES (2) ES2394349B1 (cg-RX-API-DMAC7.html)
WO (1) WO2014033343A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108290824B (zh) 2015-10-23 2022-03-11 B3Ar治疗股份有限公司 索拉贝隆两性离子及其应用
WO2022198259A1 (en) * 2021-03-25 2022-09-29 The Heart Research Institute Ltd Treatment methods for pulmonary arterial hypertension
EP4313019A4 (en) * 2021-03-31 2025-02-12 B3AR Therapeutics, Inc. Compositions of micronized solabegron and methods of use
IT202300021417A1 (it) 2023-10-13 2025-04-13 Univ Pisa Agonisti o attivatori del recettore adrenergico beta-3

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
US4338333A (en) 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
ATE1899T1 (de) 1979-06-16 1982-12-15 Beecham Group Plc Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
PT82120B (en) 1985-03-01 1988-06-16 Beecham Group Plc Process for preparing veterinary formulations containing ethanolamine derivatives
GB8528633D0 (en) 1985-11-21 1985-12-24 Beecham Group Plc Compounds
IT1204416B (it) 1986-06-27 1989-03-01 Midy Spa Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
GB8801306D0 (en) 1988-01-21 1988-02-17 Ici Plc Chemical compounds
ATE144139T1 (de) 1989-06-13 1996-11-15 Sanofi Sa Verwendung von phenylethanolaminen zur herstellung von medikamenten gegen augenleiden
GB8925032D0 (en) 1989-11-06 1989-12-28 Ici Plc Chemical compounds
US5061727A (en) 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
ATE185564T1 (de) 1992-08-31 1999-10-15 Sankyo Co Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
US5578638A (en) 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5776983A (en) 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
NO303782B1 (no) 1994-03-23 1998-08-31 Sankyo Co Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
US5705515A (en) 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
IL113410A (en) 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
JP3100165B2 (ja) 1994-11-29 2000-10-16 大日本製薬株式会社 インドール誘導体
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
ES2158996T3 (es) 1995-09-21 2001-09-16 Lilly Co Eli Agonistas beta3 adrenergicos selectivos.
ZA967892B (en) 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
CZ126598A3 (cs) 1995-10-26 1998-09-16 Mitsubishi-Tokyo Pharmaceuticals, Inc. Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
WO1997025311A1 (en) 1996-01-10 1997-07-17 Asahi Kasei Kogyo Kabushiki Kaisha Novel tricyclic compounds and drug compositions containing the same
US5770615A (en) 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
EP0801060A1 (en) 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
JP2000511903A (ja) 1996-06-07 2000-09-12 メルク エンド カンパニー インコーポレーテッド 糖尿病および肥満の治療のための選択性β▲下3▼作動薬としてのオキサジアゾール・ベンゼンスルホンアミド
EP0827746B1 (en) 1996-09-05 2002-04-03 Eli Lilly And Company Carbazole analogues as selective beta3 adrenergic agonists
IL131130A0 (en) 1997-01-28 2001-01-28 Merck & Co Inc Thiazole benzenesulfonamides as beta3 agonists for the treatment of diabetes and obesity
AU735249B2 (en) 1997-07-03 2001-07-05 Asahi Kasei Kabushiki Kaisha Novel tricyclic compounds having saturated rings and medicinal compositions containing the same
HUP0301329A2 (hu) 2000-07-13 2003-08-28 Eli Lilly And Co. Béta3 Adrenergiás agonisták, valamint ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás e vegyületek előállítására
US6537994B2 (en) 2000-07-17 2003-03-25 Wyeth Heterocyclic β3 adrenergic receptor agonists
US20040242485A1 (en) 2003-05-30 2004-12-02 Takashi Kadowaki Compositions and methods for the amelioration of leptin resistance
CN103068400A (zh) 2010-06-25 2013-04-24 阿斯顿大学 具有脂类动员性质的糖蛋白及其治疗用途
CN102764438A (zh) 2012-01-30 2012-11-07 林曙光 β3肾上腺素受体激动剂的新用途

Similar Documents

Publication Publication Date Title
JP2018520455A5 (cg-RX-API-DMAC7.html)
JP2017514910A5 (cg-RX-API-DMAC7.html)
JP2018024682A5 (cg-RX-API-DMAC7.html)
JP2019048894A5 (cg-RX-API-DMAC7.html)
JP2018521020A5 (cg-RX-API-DMAC7.html)
JP2009535462A5 (cg-RX-API-DMAC7.html)
JP2011500550A5 (cg-RX-API-DMAC7.html)
JP2014515013A5 (cg-RX-API-DMAC7.html)
JP2017528503A5 (cg-RX-API-DMAC7.html)
JP2016540742A5 (cg-RX-API-DMAC7.html)
JP2009502793A5 (cg-RX-API-DMAC7.html)
JP2016518337A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2014062126A5 (cg-RX-API-DMAC7.html)
JP2013532130A5 (cg-RX-API-DMAC7.html)
JP2012513416A5 (cg-RX-API-DMAC7.html)
JP2011513410A5 (cg-RX-API-DMAC7.html)
JP2016505637A5 (cg-RX-API-DMAC7.html)
JP2015199738A5 (cg-RX-API-DMAC7.html)
JP2017511377A5 (cg-RX-API-DMAC7.html)
JP2016529306A5 (cg-RX-API-DMAC7.html)
JP2012507535A5 (cg-RX-API-DMAC7.html)
JP2016522835A5 (cg-RX-API-DMAC7.html)
JP2010521516A5 (cg-RX-API-DMAC7.html)
JP2016125056A5 (cg-RX-API-DMAC7.html)